These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2483168)

  • 21. Reversible obesity-related glomerulopathy following weight reduction.
    Tran HA
    Med J Aust; 2006 Apr; 184(7):367. PubMed ID: 16584378
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatitis-B-associated glomerulonephritis in children.
    Oner A; Tinaztepe K; Demircin G
    Turk J Pediatr; 1997; 39(2):239-46. PubMed ID: 9223922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria?
    Rezende GM; Viana VS; Malheiros DM; Borba EF; Silva NA; Silva C; Leon EP; Noronha IL; Bonfa E
    Lupus; 2014 Mar; 23(3):255-62. PubMed ID: 24356611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of antiviral therapy on hepatitis C virus related glomerulopathy.
    Abbas G; Hussain S; Shafi T
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):775-80. PubMed ID: 18711294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Extrahepatic manifestations in hepatitis C. Are they overlooked?].
    Kristiansen MG; Florholmen J
    Tidsskr Nor Laegeforen; 2001 Feb; 121(4):446-9. PubMed ID: 11255860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of proteinuria in a case of hepatitis B-associated glomerulonephritis after treatment with interferon.
    Mizushima N; Kanai K; Matsuda H; Matsumoto M; Tamakoshi K; Ishii H; Nakajima T; Yoshimi T; Kimura M; Nagase M
    Gastroenterology; 1987 Feb; 92(2):524-6. PubMed ID: 3792787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential localization of s and e antigens in hepatitis B virus-associated glomerulonephritis.
    Ohba S; Kimura K; Mise N; Konno Y; Suzuki N; Miyashita K; Tojo A; Hirata Y; Uehara Y; Atarashi K; Goto A; Omata M
    Clin Nephrol; 1997 Jul; 48(1):44-7. PubMed ID: 9247778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Separate and combined effects of an ACE-inhibitor and low-protein low-phosphorus diet in chronic proteinuric glomerular nephropathies].
    Cusaro C; Barbè MC; Chiarinotti D; Ragazzoni E; De Leo M; Guida GE; Navino C; Pecora S; Peona C; Verzetti G
    Minerva Urol Nefrol; 1988; 40(4):295-9. PubMed ID: 2855185
    [No Abstract]   [Full Text] [Related]  

  • 29. Virological features of hepatitis B virus-associated nephropathy in Japan.
    Kusakabe A; Tanaka Y; Kurbanov F; Goto K; Tajiri H; Murakami J; Okuse C; Yotsuyanagi H; Joh T; Mizokami M
    J Med Virol; 2007 Sep; 79(9):1305-11. PubMed ID: 17607789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Late results and prognosis in glomerulonephritis. II. Prognosis in specific forms of glomerulopathies].
    Hruby Z
    Przegl Lek; 1992; 49(1-2):28-30. PubMed ID: 1455001
    [No Abstract]   [Full Text] [Related]  

  • 31. Membranous nephropathy following perinatal transmission of hepatitis B virus infection--long-term follow-up study.
    Levy M; Gagnadoux MF
    Pediatr Nephrol; 1996 Feb; 10(1):76-8. PubMed ID: 8611364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon treatment of hepatitis B-associated membranous glomerulonephritis and nephrotic syndrome.
    Giboa N; Neigut D
    Pediatr Nephrol; 1993 Jun; 7(3):328-9. PubMed ID: 8518110
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of some immunologic indices in children with HBV-mediated membranous glomerulonephritis.
    Jung H
    Arch Immunol Ther Exp (Warsz); 1988; 36(5):567-77. PubMed ID: 3268070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical antiglomerular basement membranes disease with nephrotic-range proteinuria, mesangial proliferation, and membranoproliferative glomerulonephritis pattern of injury.
    AlSowailmi B; AlSowailmi G; Aloudah N; Alsaad KO; Elhassan E; Al Sayyari AA
    Saudi J Kidney Dis Transpl; 2017; 28(6):1397-1403. PubMed ID: 29265053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon.
    Chung DR; Yang WS; Kim SB; Yu E; Chung YH; Lee Y; Park JS
    Am J Nephrol; 1997; 17(2):112-7. PubMed ID: 9096440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membranous nephropathy associated with chronic hepatitis B occurring in a short period after acute hepatitis B virus infection.
    Nakahara K; Takahashi H; Okuse C; Shigefuku R; Yamada N; Murao M; Matsunaga K; Koike J; Yotsuyanagi H; Suzuki M; Kimura K; Itoh F
    Intern Med; 2010; 49(5):383-8. PubMed ID: 20190469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of HBe antibody in glomerular deposits in membranous glomerulonephritis is associated with hepatitis B virus infection.
    Hattori S; Furuse A; Matsuda I
    Am J Nephrol; 1988; 8(5):384-7. PubMed ID: 3239599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remission of proteinuria with treatment of Actinomyces infection: eradicating a cause of secondary membranous glomerulopathy suppresses nephrotic syndrome.
    Yoon SY; Lee SC; Park YJ; Rha SH
    Nephrol Dial Transplant; 2009 Oct; 24(10):3236-9. PubMed ID: 19515799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of hepatitis B virus-related membranoproliferative glomerulonephritis after orthotopic liver transplantation.
    Quan A; Portale A; Foster S; Lavine J
    Pediatr Nephrol; 1995 Oct; 9(5):599-602. PubMed ID: 8580018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
    Ozdamar SO; Gucer S; Tinaztepe K
    Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.